Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
Step one of the current British asthma guidelines recommends
that inhaled short acting
2 agonists should be used as
required. Some clinicians, including George Strube, a general
practitioner from Crawley, believe that this step is unnecessary and
that steroids should be introduced earlier. Michael Rudolph, a
consultant physician from Ealing Hospital, defends the guidelines.
George Strube 33 Goffs Park
Road, Crawley, West Sussex RH11 8AX
GStrube@aol.com
Evidence for the inflammatory basis of asthma comes
from bronchial biopsies, which show inflammation of the mucosa
even in patients with mild intermittent asthma.1 Mucosal
oedema and excess mucus production cause reduction in the lumen and
obstruction to airflow. Bronchospasm occurs as the natural "foreign
body" response to irritation caused by inflammation, the bronchi
become hyperactive and the airflow is further reduced. Persistent
inflammation may lead to structural changes in the airways, with
reduction in lung function and irreversible airways
obstruction.2
Steroids and Steroids are the most effective anti-inflammatory drugs available.
They reduce mucosal oedema and
agonists
Read all Rapid Responses